NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink
Natalia Elliot | November 5, 2024 | News story | Research and Development | NorthWest Ehealth, clinical trials
The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies and opportunities for people to take part in research and access innovative new medicines.
The pilot will test a new model combining NWEH’s secure, tried and tested FARSITE platform, with the scale and depth of CPRD’s 18-million anonymised patient records, using secure and remote access, without transferring data between the organisations, enabling clinical trial feasibility studies and find-and-refer services at a speed and scale not previously possible in the UK.
5 November 2024 – Manchester, UK –: NorthWest EHealth (NWEH) has announced a pilot of a new model for safely and securely finding participants for clinical trials, using the Medicine and Healthcare product Regulatory Agency’s (MHRA) Clinical Practice Research Datalink (CPRD) data services. This initiative aims to improve the speed, scale, inclusivity and representativeness of participants found for novel clinical trials.
Current approaches to finding suitable participants for clinical trials can frequently take weeks or months, often leading to more costs and delays. The new model being piloted combines the speed of NWEH’s secure FARSITE platform with more than 18-million anonymised patient records, provided by the CPRD data service. This new approach would mean more diverse and inclusive clinical trials in the UK, as well as finding participants more quickly and efficiently.
NWEH’s FARSITE is a secure platform that enables rapid feasibility across a representative population, while preserving participant anonymity. It accurately finds potential trial participants with pin-point accuracy through easy-to-use inclusion and exclusion criteria when inputting information. This unlocks potential participant pools for find-and-refer services who are then contacted directly by their GP practices, increasing opportunities for people to participate in clinical trials.
If successful, the new model could result in enhanced innovation and efficiencies in medical research, improving public access to clinical trials, to support the discovery and validation of advanced approaches to treatment and be expanded across the UK.
Jonathan Wogel, Chief Executive Officer of NWEH, said: “We are excited to announce this pilot initiative, which aims to support the nation’s life sciences sector by accelerating and optimising the set-up of clinical trials in the UK. By combining our agile and innovative FARSITE technology with CPRD data, clinical trial feasibility and find-and-refer services can be conducted more quickly, with more precise determination of the most relevant clinical trial participants, including under-served populations. This, in turn, can reduce costs and support more robust studies optimised to help improve health outcomes for patients, once again positioning the UK as a leader in clinical research.”
About Northwest EHealth: NWEH is a Manchester based pioneer in clinical trial technologies, using transformative solutions and expertise to streamline clinical trial management, for trials that are smarter, faster and truer-to-life.
Related Content
Vesper Bio reports positive topline results for dementia candidate
Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has …
Von Willebrand disease – increasing awareness and access to vital care
Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …
Rethinking oncology trial endpoints with generalised pairwise comparisons
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …
